152 related articles for article (PubMed ID: 37839054)
1. In silico and in vitro metabolism studies of the new synthetic opiate AP-237 (bucinnazine) using bioinformatics tools.
Pelletier R; Bourdais A; Fabresse N; Ferron PJ; Morel I; Gicquel T; Le Daré B
Arch Toxicol; 2024 Jan; 98(1):165-179. PubMed ID: 37839054
[TBL] [Abstract][Full Text] [Related]
2. Use of innovative, cross-disciplinary in vitro, in silico and in vivo approaches to characterize the metabolism of chloro-alpha-pyrrolidinovalerophenone (4-Cl-PVP).
Pelletier R; Le Daré B; Ferron PJ; Le Bouëdec D; Kernalléguen A; Morel I; Gicquel T
Arch Toxicol; 2023 Mar; 97(3):671-683. PubMed ID: 36469093
[TBL] [Abstract][Full Text] [Related]
3. Case report: Identification of AP-238 and 2-fluorodeschloroketamine in internet available powder samples sold as bucinnazine.
Resnik KN; Babb KN; Bekenstein LW; Moeller FG; Peace MR; Alves EA
Forensic Sci Int; 2023 Jul; 348():111732. PubMed ID: 37216788
[TBL] [Abstract][Full Text] [Related]
4. New Synthetic Opioids Use among Patients in Treatment for an Opioid Use Disorder in Barcelona.
Alías-Ferri M; Marchei E; Pacifici R; Pichini S; Pellegrini M; Pérez-Mañá C; Papaseit E; Muga R; Fonseca F; Farré M; Torrens M
Eur Addict Res; 2022; 28(5):323-330. PubMed ID: 35378545
[TBL] [Abstract][Full Text] [Related]
5. Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers.
Marchei E; Ferri MA; Torrens M; Farré M; Pacifici R; Pichini S; Pellegrini M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924438
[TBL] [Abstract][Full Text] [Related]
6. Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700.
Richeval C; Gaulier JM; Romeuf L; Allorge D; Gaillard Y
Int J Legal Med; 2019 Jan; 133(1):133-142. PubMed ID: 30443678
[TBL] [Abstract][Full Text] [Related]
7. A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline.
Pelletier R; Gicquel T; Simoes Eugenio M; Ferron PJ; Morel I; Delehouzé C; Dimanche-Boitrel MT; Rousselot M; Le Daré B
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559159
[TBL] [Abstract][Full Text] [Related]
8. DARK Classics in Chemical Neuroscience: Bucinnazine.
Resnik K; Brandão P; Alves EA
ACS Chem Neurosci; 2021 Oct; 12(19):3527-3534. PubMed ID: 34528782
[TBL] [Abstract][Full Text] [Related]
9. In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl.
Richeval C; Gicquel T; Hugbart C; Le Dare B; Allorge D; Morel I; Gaulier JM
Curr Pharm Biotechnol; 2017; 18(10):806-814. PubMed ID: 29173157
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and metabolic characterization of the novel synthetic opioid brorphine and its detection in routine casework.
Grafinger KE; Wilde M; Otte L; Auwärter V
Forensic Sci Int; 2021 Oct; 327():110989. PubMed ID: 34509061
[TBL] [Abstract][Full Text] [Related]
11. Identification of etazene (etodesnitazene) metabolites in human urine by LC-HRMS.
Verougstraete N; Verhaeghe A; Germonpré J; Lebbinck H; Verstraete AG
Drug Test Anal; 2023 Feb; 15(2):235-239. PubMed ID: 36181239
[TBL] [Abstract][Full Text] [Related]
12. Metabolite elucidation of 2-fluoro-deschloroketamine (2F-DCK) using molecular networking across three complementary in vitro and in vivo models.
Gicquel T; Pelletier R; Richeval C; Gish A; Hakim F; Ferron PJ; Mesli V; Allorge D; Morel I; Gaulier JM
Drug Test Anal; 2022 Jan; 14(1):144-153. PubMed ID: 34515415
[TBL] [Abstract][Full Text] [Related]
13. Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238.
Fogarty MF; Vandeputte MM; Krotulski AJ; Papsun D; Walton SE; Stove CP; Logan BK
Arch Toxicol; 2022 Jun; 96(6):1701-1710. PubMed ID: 35275255
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of
Al-Shakliah NS; Attwa MW; AlRabiah H; Kadi AA
Anal Methods; 2021 Jan; 13(3):399-410. PubMed ID: 33410830
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
Cutler C; Hudson S
Drug Test Anal; 2019 Aug; 11(8):1134-1143. PubMed ID: 31081594
[TBL] [Abstract][Full Text] [Related]
16. Detection of AP-237 and synthetic cannabinoids on an infused letter sent to a German prisoner.
Giorgetti A; Brunetti P; Pelotti S; Auwärter V
Drug Test Anal; 2022 Oct; 14(10):1779-1784. PubMed ID: 35918775
[TBL] [Abstract][Full Text] [Related]
17. Fatal intoxication involving 2-methyl AP-237.
Truver MT; Crosby MM; Gillette AT; Brogan SC; Hoyer JL; Chronister CW; Broussard WA; Vega RS; Goldberger BA
J Forensic Sci; 2023 Jul; 68(4):1419-1424. PubMed ID: 37264551
[TBL] [Abstract][Full Text] [Related]
18. Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl.
Gampfer TM; Wagmann L; Richter MJ; Fischmann S; Westphal F; Meyer MR
J Anal Toxicol; 2020 Apr; 44(5):449-460. PubMed ID: 32020187
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein binding.
Gampfer TM; Richter LHJ; Schäper J; Wagmann L; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1572-1580. PubMed ID: 31424163
[TBL] [Abstract][Full Text] [Related]
20. A multi-dimensional liquid chromatography/high-resolution mass spectrometry approach combined with computational data processing for the comprehensive characterization of the multicomponents from Cuscuta chinensis.
Wang M; Xu XY; Wang HD; Wang HM; Liu MY; Hu WD; Chen BX; Jiang MT; Qi J; Li XH; Yang WZ; Gao XM
J Chromatogr A; 2022 Jul; 1675():463162. PubMed ID: 35635871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
